208 related articles for article (PubMed ID: 15178516)
1. Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome.
Isaacsohn JL; Troendle AJ; Orloff DG
Am J Cardiol; 2004 Jun; 93(11A):49C-52C. PubMed ID: 15178516
[No Abstract] [Full Text] [Related]
2. Free fatty acid receptor family: novel targets for the treatment of diabetes and dyslipidemia.
Bernard J
Curr Opin Investig Drugs; 2008 Oct; 9(10):1078-83. PubMed ID: 18821469
[TBL] [Abstract][Full Text] [Related]
3. [New developments in the treatment of diabetes and hyperlipidemias].
Ducobu J
Rev Med Brux; 1998 Sep; 19(4):A379-85. PubMed ID: 9805978
[TBL] [Abstract][Full Text] [Related]
4. Novel diabetes drugs to face higher hurdles?
Opar A
Nat Rev Drug Discov; 2007 Sep; 6(9):687-9. PubMed ID: 17907340
[No Abstract] [Full Text] [Related]
5. American Diabetes Association--66th scientific sessions. Updates on drug treatments. 9-13 June 2006, Washington, DC, USA.
Jago C
IDrugs; 2006 Aug; 9(8):542-4. PubMed ID: 16871460
[No Abstract] [Full Text] [Related]
6. Drug therapy in the heart transplant recipient: Part III: common medical problems.
Lindenfeld J; Page RL; Zolty R; Shakar SF; Levi M; Lowes B; Wolfel EE; Miller GG
Circulation; 2005 Jan; 111(1):113-7. PubMed ID: 15630040
[No Abstract] [Full Text] [Related]
7. Management of atherogenic dyslipidemia of the metabolic syndrome: evolving rationale for combined drug therapy.
Vega GL
Endocrinol Metab Clin North Am; 2004 Sep; 33(3):525-44, vi. PubMed ID: 15262295
[TBL] [Abstract][Full Text] [Related]
8. Statement on fixed ratio combinations of drugs.
Moss JM
Va Med Mon (1918); 1971 Sep; 98(9):472-3. PubMed ID: 5119159
[No Abstract] [Full Text] [Related]
9. Pharmacologic treatment of type 2 diabetic dyslipidemia.
Moon YS; Kashyap ML
Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
[TBL] [Abstract][Full Text] [Related]
10. Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.
Misbin RI
Diabetes Care; 2007 Dec; 30(12):3141-4. PubMed ID: 18042753
[No Abstract] [Full Text] [Related]
11. New treatments for diabetes.
Irony I; Parks MH; Meyer RJ
N Engl J Med; 2007 May; 356(21):2221; author reply 2222-3. PubMed ID: 17526095
[No Abstract] [Full Text] [Related]
12. Normalization of metabolic syndrome using fenofibrate, metformin or their combination.
Nieuwdorp M; Stroes ES; Kastelein JJ;
Diabetes Obes Metab; 2007 Nov; 9(6):869-78. PubMed ID: 17924869
[TBL] [Abstract][Full Text] [Related]
13. New treatments for diabetes.
Raz I; Eldor R
N Engl J Med; 2007 May; 356(21):2222; author reply 2222-3. PubMed ID: 17526096
[No Abstract] [Full Text] [Related]
14. Drug development research: diabetes favored over cardiovascular disease?
Suckling K
Curr Opin Investig Drugs; 2009 Mar; 10(3):217-9. PubMed ID: 19333877
[No Abstract] [Full Text] [Related]
15. Dyslipidemia in type 2 diabetes.
Krauss RM; Siri PW
Med Clin North Am; 2004 Jul; 88(4):897-909, x. PubMed ID: 15308384
[TBL] [Abstract][Full Text] [Related]
16. Use of pharmacologic agents for treatment of diabetes mellitus, dyslipidemia, and hypertension in children and adolescents.
Daniels SR
Arch Pediatr Adolesc Med; 2009 Apr; 163(4):389-91. PubMed ID: 19349572
[No Abstract] [Full Text] [Related]
17. Prevention and treatment of the metabolic syndrome in the elderly.
Firdaus M
J Okla State Med Assoc; 2005 Feb; 98(2):63-6. PubMed ID: 15789643
[TBL] [Abstract][Full Text] [Related]
18. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and treatment of metabolic syndrome in adolescents with type 2 diabetes.
Sanders BH; Lubsch LM; West DS
Ann Pharmacother; 2006 Sep; 40(9):1517-21. PubMed ID: 16896016
[TBL] [Abstract][Full Text] [Related]
20. Early pharmacological intervention in newly diagnosed metabolic syndrome and type 2 diabetes.
Naruszewicz M
Przegl Lek; 2006; 63 Suppl 4():7-8. PubMed ID: 16967707
[No Abstract] [Full Text] [Related]
[Next] [New Search]
